Macquarie lifts F&P price target by 7.3pc
Macquarie Group lifted its 12-month target price on F&P Healthcare by 7.3 per cent
AdvertisementAdvertise with NZME.
Latest from Fisher and Paykel Healthcare
F&P Healthcare positive about future
Profit rose to a record $169m in the 12 months ended March 31, from $143m a year earlier.
Do young companies need a board to grow?
COMMENT: Problems can rise in scaling start-ups into a larger sustainable company.
F&P's new boss, just like the old boss
Business as usual is delivering results for healthcare company's chief executive.
SFO charges former F&P Healthcare manager
Former F&P healthcare manager pleads guilty to charges.
Improving board effectiveness
COMMENT: Boardroom conversation is an art form for some and a learned skill for others.
F&P's cunning plan to avoid Trump's tax
US President plans a 20% tax on goods from Mexico, where F&P Healthcare manufactures medical equipment, but the Kiwi company has a work-around.
Are directors performing at their best?
COMMENT: Governance cannot be that bad, given the growing interest in directorships from many individuals.
Former F&P Healthcare boss wins top award
Michael Daniell has won the New Zealand Shareholders Association's 2016 Beacon Award
F&P Healthcare posts 26pc gain
Fisher & Paykel Healthcare, the medical device maker, increased first-half profit 26 per cent and widened its margins.
F&P files patent infringement against ResMed
F&P Healthcare has filed a patent infringement lawsuit against ResMed, claiming it used its tech in its breathing masks and air flow products.
Portfolio manager bought shares to push up price, court told
Details of the case against Milford Asset Management's Mark Warminger were revealed in court today.
F&P Healthcare profit jumps 27pc
Fisher & Paykel Healthcare beat its forecast for annual profit, boosting revenue and margins.
Henri Eliot: Do you want to know the skill set of company directors?
Henri Eliot talks publishing a skills matrix that provides shareholders with the information needed to evaluate a board's skill set mix.
Diligent, F&P tipped as stars of next year
Brokers are picking Fisher & Paykel Healthcare, Diligent and Infratil to be among the NZX's top-performing stocks in 2016.
Henri Eliot: What should worry directors in 2016?
Henri Eliot talks to professional directors Mark Verbiest, Tony Carter, Doug McKay and Rob Campbell about their focal points in 2016.
F&P Healthcare record profit rise
Fisher & Paykel Healthcare's first-half profit rose to a record $62 million.
F&P Finance sale battle hotting up
Efforts to sell Fisher & Paykel Finance are gathering momentum, but mixed messages are emerging over when the deal might be clinched.
F&P Healthcare boss steps down
The departure of Fisher & Paykel Healthcare chief executive Mike Daniell might unsettle some investors but is unlikely to derail the company, say market players.
F&P Healthcare's Daniell retires, upgrades guidance
F&P Healthcare's boss Mike Daniell says he'll retire this year, as the company announces an upgrade to its earnings guidance.
Diana Siew: Collaboration helps New Zealand med-tech sector take on world
When people talk about the New Zealand health technology sector, they tend to think about two companies - Orion Health and Fisher & Paykel Healthcare.
Stock Takes: Good prognosis for F&P Healthcare
Fisher & Paykel Healthcare reported yet another record full-year profit last Friday, justifying Craigs' consistently bullish view.
F&P Healthcare earnings to increase further
Fisher & Paykel Healthcare beat its forecast annual profit and said earnings would rise further in the coming year.
F&P Healthcare record result tipped
Fisher & Paykel Healthcare could beat its own guidance for a record-breaking annual profit when its full-year result is revealed on Friday, a broker says.
Second day of falls for NZ shares
New Zealand shares fell for a second day as the kiwi dollar's slide to a four-year low sapped overseas investor appetite for high-yielding stocks.
Dynamic Business: Chairperson of the Year - Tony Carter Air NZ, F&P Healthcare
Chairperson of the Year Tony Carter is known to be a strong believer in diversity in the boardroom.
Profit lift boosts F&P Healthcare
Fisher & Paykel Healthcare shares have soared to a record high after the medical device maker's sixth profit guidance upgrade in two years.
F&P at record on higher profit
New Zealand shares rose as Fisher & Paykel Healthcare advanced to a record after lifting its annual profit guidance. Xero fell as its first-half results showed a slower pace of growth.